Pharma Co. Gets Pneumonia Drug Stock-Drop Suit Tossed

By Dean Seal (October 29, 2018, 8:41 PM EDT) -- A North Carolina judge on Friday dismissed a putative class action accusing drugmaker Cempra Inc. of failing to disclose significant risks associated with an experimental antibiotic used to treat pneumonia, finding the complaint's allegations did not raise the inference that Cempra or its officers intended to mislead investors....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!